TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Polyphyllin I, Enzalutamide
Phytochemical Name Polyphyllin I (PubChem CID: 72960700 )
Anticancer drug Name Enzalutamide (PubChem CID: 15951529 )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 359
Pair Name Polyphyllin I, Enzalutamide
Disease Info [ICD-11: 2C12] Hepatocellular carcinoma Investigative
Gene Regulation Down-regulation Expression MUC1 hsa4582
Down-regulation Expression RELA hsa5970
In Vitro Model DU145 Prostate carcinoma Homo sapiens (Human) CVCL_0105
PC-3 Prostate carcinoma Homo sapiens (Human) CVCL_0035
In Vivo Model DU145 prostate cancer cells carrying the luciferase report gene (1×10⁶ cells) in 100 µL PBS were implanted via subcutaneous injection into the flanks of the mice.
Result Our results indicate that PPI inhibits the growth of CRPC cells by inhibiting p65 protein and concomitantly reducing HOTAIR expression, thereby suppressing MUC1 gene expression. The novel regulatory interaction of p65 and HOTAIR converge in the inhibition of MUC1 expression and overall PPI response. The combination of PPI and enzalutamide exhibits synergy. This study reveals a novel mechanism underlying the synergistic inhibitory effect of PPI and enzalutamide on the growth of CRPC cells.
03. Reference
No. Title Href
1 Crosstalk of NF-κB/P65 and LncRNA HOTAIR-Mediated Repression of MUC1 Expression Contribute to Synergistic Inhibition of Castration-Resistant Prostate Cancer by Polyphyllin 1-Enzalutamide Combination Treatment. Cell Physiol Biochem. 2018;47(2):759-773. doi: 10.1159/000490028. Click
It has been 48660 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP